Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2869-2877

  Taneja, Veena ^a   Behrens, Marshall ^a   Basal, Eati ^a   Sparks, Josh ^d   Griffiths, Marie M ^b   Luthra, Harvinder ^c   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d BEREA COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 2; EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DQ8 ANTIGEN; HLA-DRB1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC COMPLEMENTATION; HUMORAL IMMUNITY; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; THYMUS; TRANSGENIC MOUSE; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CLONAL DELETION; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 53149102866     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2869     Document Type: Article

References (55)

1. Newton, J. L., S. M. J. Harney, B. P. Wordsworth, and M. A. Brown. 2004. A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 5: 151-157.
2. Taneja, V., M. J. Giphart, W. Verduijn, A. Naipal, A. N. Malaviya, and N. K. Mehra. 1996. Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum. Immunol. 46: 35-40.
3. Stastny, P. 1978. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298: 869-871.
4. Nepom, G. T., and B. S. Nepom. 1992. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum. Dis. Clin. N. Am. 18: 785-792.
5. Wordsworth, B. P., J. S. Lanchbury, L. I. Sakkas, K. I. Welsh, G. S. Panayi, and J. I. Bell. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. Natl. Acad. Sci. USA 86: 10049-10053.
6. Gregersen, P. K., J. Silver, and R. J. Winchester. 1987. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30: 1205-1213.
7. Winchester, R., E. Dawyer, and S. Rose. 1992. The genetic basis of rheumatoid arthritis: the shared epitope hypothesis. Rheum. Dis. Clin. N. Am. 18: 761-783.
8. Mitchison, N. A. 1992. Specialization, tolerance, memory, competition, latency, and strife among T cells. Annu. Rev. Immunol. 10: 1-12.
9. Moller, E., J. Bohme, M. A. Valugerdi, A. Ridderstad, and O. Olerup. 1990. Speculations on the mechanism of HLA association with autoimmune diseases and the specificity of autoreactive T lymphocytes. Immunol. Rev. 118: 5-19.
10. Kirschmann, D. A., K. L. Duffin, C. E. Smith, J. K. Welply, S. C. Howard, B. D. Schwartz, and S. L. Woulfe. 1995. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J. Immunol. 155: 5655-5662.
11. Snijders, A., D. G. Elferink, A. Geluk, A. L. van Der Zanden, K. Vos, G. M. Schreuder, F. C. Breedveld, R. R. de Vries, and E. H. Zanelli. 2001. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs. J. Immunol. 166: 4987-4993.
12. Zanelli, E., M. A. Gonzalez-Gay, and C. S. David. 1995. Could DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today 16: 274-278.
13. Taneja, V., and C. S. David. 1998. HLA class II transgenic mice as humanized mouse models disease and immunity. J. Clin. Invest. 101: 921-926.
14. Matsushita, S., T. Nishi, M. Oiso, K. Yamaoka, K. Yone, T. Kanai, and Y. Nishimura. 1996. HLA-DQ-binding motifs: I. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int. Immunol. 8: 757-764.
15. Krco, C. J., J. Pawelski, J. Harders, I. McCormick, M. M. Griffiths, H. S. Luthra, and C. S. David. 1996. Characterization of the antigenic structure of human type II collagen. J. Immunol. 156: 2761-2768.
16. Begovich, A. B., G. R. McClure, V. C. Suraj, R. C. Helmuth, N. Fildes, T. L. Bugawan, H. A. Erlich, and W. Klitz. 1992. Polymorphism recombination and linkage disequilibrium within the HLA class II region. J. Immunol. 148: 249-258.
17. Taneja, V., N. K. Mehra, A. N. Chadreshekaran, R. K. Ahuja, Y. N. Singh, and A. N. Malaviya,. 1992. HLA-DR4-DQw8 but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatol. Int. 11: 251-255.
18. Laivoranta-Nyman, S., T. Mottonen, R. Hermann, J. Tuokko, M. Hakala, R. Luukainen, P. Hannonen, M. Korpela, U. Yli-Kerttula, and A. Toivanen. 2004. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann. Rheum. Dis. 63: 1406-1412.
19. Cook, A. D., R. Gray, J. Ramshaw, I. R. Mackay, and M. J. Rowley. 2004. Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis. Arthritis Res. Ther. 6: R477-R483.
20. He, X., A. H. Kang, and J. M. Stuart. 2000. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 27: 589-593.
21. Nishimura, K., D. Sugiyama, Y. Kogata, G. Tsuji, T. Nakazawa, S. Kawano, K. Saigo, A. Morinobu, M. Koshiba, K. M. Kuntz, et al. 2007. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann. Intern. Med. 146: 797-808.
22. Taneja, V., N. Taneja, T. Paisansinsup, M. Behrens, M. M. Griffiths, H. S. Luthra, and C. S. David. 2002. CD4 and CD8 T cells in susceptibility/ protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: implications for rheumatoid arthritis. J. Immunol. 168: 5867-5875.
23. Taneja, V., M. M. Griffiths, H. S. Luthra, and C. S. David. 1998. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int. Immunol. 10: 1449-1457.
24. Taneja, V., M. Behrens, A. Mangalam, M. M. Griffiths, H. S. Luthra, and C. S. David. 2007. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum. 56: 69-78.
25. Taneja, V., N. Taneja, M. Behrens, S. Pan, T. Trejo, M. M. Griffiths, H. S. Luthra, and C. S. David. 2003. HLA-DRB1*0402 (*0402) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (*0401) transgenic mice from arthritis. J. Immunol. 171: 4431-4438.
26. Kouskoff, V., H. J. Fehling, M. Lemeur, C. Benoist, and D. Mathis. 1993. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J. Immunol. Methods 166: 287-291.
27. Griffiths, M. M., E. J. Eichwald, J. H. Martin, C. B. Smith, and C. W. DeWitt. 1981. Immunogenetic control of experimental type II collagen induced arthritis. Arthritis Rheum. 24: 781-789.
28. Wooley, P. H., H. S. Luthra, J. M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice: I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154: 688-700.
29. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the TH17 lineage. Nature 441: 231-234.
30. Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282: 9358-9363.
31. Stratmann, T., N. Martin-Orozco, V. Mallet-Designe, L. Poirot, D. McGavern, G. Losyev, C. M. Dobbs, M. B. A. Oldstone, K. Yoshida, H. Kikutani, et al. 2003. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 112: 902-914.
32. Haqqi, T. M., G. D. Anderson, S. Banerjee, and C. S. David. 1992. Restricted heterogeneity in T-cell antigen receptor Vβ gene usage in lymph nodes and arthritic joints of mice. Proc. Natl. Acad. Sci. USA 89: 1253-1255.
33. Chaturvedi, P., B. Agarwal, M. Zechel, E. Lee-Chan, and B. Singh. 2000. A self MHC class II β-chain peptide prevents diabetes in nonobese diabetic mice. J. Immunol. 164: 6610-6620.
34. Khani-Hanjani, A., D. Lacaille, C. Horne, A. Chalmers, D. I. Hoar, R. Balshaw, and P. A. Keown. 2002. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis. J. Rheumatol. 29: 1358-1365.
35. Ji, H., A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist. 2002. Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis. J. Exp. Med. 196: 77-85.
36. Nguyen, L. T., J. Jacobs, D. Mathis, and C. Benoist. 2007. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56: 509-520.
37. + immunoregulatory T cells may not be involved in controlling autoimmune arthritis. Arthritis Res. Ther. 5: R106-R113.
38. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186: 1059-1075.
39. Majoly, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2: 816-822.
40. Sarkar, S., and D. A. Fox. 2007. Regulatory T cell defects in rheumatoid arthritis. Arthritis Rheum. 56: 710-713.
41. Raza, K., F. Falcani, S. J. Curnow, E. J. Ross, C. Y. Lee, A. N. Akbar, J. M. Lord, C. Gordon, C. D. Buckley, and M. Salmon. 2005. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7: R784-R795.
42. McInnes, I. B., and F. Y. Liew. 2005. Cytokine networks: towards new therapies for rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 1: 31-39.
43. Nakae, S., A. Nambu, K. Sudo and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 17: 6173-6177.
44. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
45. Sarkar, S., L. A. Tesmer, V. Hindnavis, J. L. Endres, and D. A. Fox. 2007. Interleukin-17 as a molecular target in immune-mediated arthritis. Arthritis Rheum. 56: 89-100.
46. Berg, L., J. Ronnelid, C. B. Sanjeevi, J. Lampa, and L. Klareskog. 2000. Interferon α production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1*0401 and HLA-DQ8. Arthritis Res. 2: 75-84.
47. Tokayer, A., S. E. Carsons, B. Chokshi, and F. Santiago-Schwarz. 2002. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity. J. Rheumatol. 29: 454-461.
48. van Lieshout, A., R. van der Voort, L. M. le Blanc, M. F. Roelofs, B. W. Schreurs, P. L. van Riel, G. J. Adema, and T. Radstake. 2006. Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid. BMC Immunol. 7: 23-35.
49. Geijsen, N., L. Koenderman, and P. J. Coffer. 2001. Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev. 12: 19-25.
50. Eyles, J. L., A. W. Roberts, D. Metcalf, and I. P. Wicks. 2006. Granulocyte colony-stimulating factor and neutrophils: forgotten mediators of inflammatory disease. Nat. Clin. Pract. Rheumatol. 2: 500-510.
51. Rosloniec, E. F., K. B. Whittington, D. M. Zaller, and A. H. Kang. 2002. HLADR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J. Immunol. 168: 253-259.
52. Terato, K., K. A. Hasty, M. A. Cremer, J. M. Stuart, A. S. Towens, and A. H. Kang. 1985. Collagen induced arthritis in mice: localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J. Exp. Med. 162: 637-646.
53. Diab, B. Y., N. C. Lambert, F. E. L'Faqihi, P. Loubet-Lescoulie, C. de Preval, and H. Coppin. 1999. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Immunogenetics 49: 36-44.
54. Nooh, M. M., N. El-Gengehi, R. Kansal, C. S. David, and M. Kotb. 2007. HLA transgenic mice provide a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178: 3076-3083.
55. Vanderborght, P. R., A. G. Pacheco, M. E. Moraes, G. Antoni, M. Romero, A. Verville, V. H. Thai, N. T. Huong, N. N. Ba, E. Schurr, et al. 2007. HLADRB1* 04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun. 8: 320-324.